Physician profile
Brian D Snyders
NPI 1023129244
$27,570.16
in general payments reported to CMS, 2019-2025
17 companies · $35.64 in 2025
The $35.64 reported for 2025 was less than what a typical Spinal Cord Injury Medicine provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $85.14 · 2021: $26K · 2022: $114 · 2023: $105 · 2024: $497 · 2025: $35.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.93 |
| Education | $120.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26,416.28 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $317.99 | 2024 | Dysport, Onivyde |
| Abbvie INC. | $304.60 | 2021-2025 | Qulipta, Ubrelvy |
| Amgen INC. | $134.89 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $76.42 | 2019 | |
| Pfizer INC. | $76.14 | 2023-2024 | |
| Horizon Therapeutics Plc | $53.23 | 2019-2020 | |
| Sanofi Pasteur INC. | $41.62 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.61 | 2022 | |
| Glaxosmithkline, LLC. | $20.04 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $17.11 | 2023 | Uzedy |
| Lilly USA, LLC | $16.98 | 2019 | |
| Boston Scientific Corporation | $16.95 | 2021 | |
| Corium, LLC | $16.13 | 2022 | |
| Axsome Therapeutics, INC. | $12.95 | 2023 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $11.30 | 2021 | |
| Novo Nordisk INC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Snyders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.